GeneGo and Spotfire have integrated their flagship products. This will allow users of GeneGo’s MetaCore and MetaData products to analyse genomics and proteomics data more easily and accurately in Spotfire’s DecisionSite.
DecisionSite users will be able to automatically upload chemical compounds into MetaCore and MetaDrug to study their biological effects, such as toxicity. The data can then be imported back into DecisionSite to search for additional in-house experiments.
'We received numerous requests from our mutual customers for seamless integration with Spotfire,' said Julie Bryant, vice president of business development at GeneGo. The move is an example of GeneGo’s open partnering philosophy.